TrialFuture oncology (London, England)2025

A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G.

Munehiro Wakabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.